Refer a Patient "*" indicates required fields Patient name* First Patient email address* Patient phone numberReferring Primary Nephrologist Institution* Referring Primary Nephrologist/Key Contact* The patient's contact information will be sent to a team at Patient information will be kept confidential and will never be sold or shared with outside vendors.If you would like to be included on future communications about this referral, please fill in your email addressYour email address Study TitleA Phase 2 Study to Evaluate the Safety and Biologic Activity of APL- 2 in Patients With IgA Nephropathy, Lupus Nephritis, Primary Membranous Nephropathy, or C3 Glomerulopathy (C3 Glomerulonephritis and Dense Deposit Disease)HiddenStudy Email HiddenStudy Marketing TitleThe Discovery Trial for IgAN, MN, LN, and C3G PatientsHiddenSite NameApellis Investigational SiteHiddenSite LocationAlexandria, VA.HiddenUser Role NameThis field is for validation purposes and should be left unchanged. Sign up to get NephCure’s latest updates. SIGN UP Email(Required) CommentsThis field is for validation purposes and should be left unchanged.